← Eichor
Study identifier: NCT04971577 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy of Simvastatin in Alcoholic Liver Fibrosis

Condition: Liver Fibrosis · Alcohol Abuse  ·  Sponsor: Anna Cruceta

PhasePhase 2/Phase 3
Planned participants90
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Evaluate the efficacy of simvastatin in reducing liver fibrosis in patients with advanced fibrosis due to alcohol

This description comes directly from the study's public registry record.

Talk to the study team

Gratacos  ·  34 932275400  ·  acruceta@recerca.clinic.cat

ana cruceta  ·  34-932275400  ·  acruceta@recerca.clinic.cat

Always discuss trial participation with your own doctor first.

Locations (1)

Jordi GratacosBarcelona, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04971577